Please check your internet connection and try again.
# Lorazepam (representative benzodiazepine)
## Overview
Lorazepam is a benzodiazepine medication that enhances the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABAA receptor, resulting in sedative, hypnotic, anxiolytic, anticonvulsant, and muscle relaxant properties.
## Primary Indications
* Anxiety disorders
* Insomnia due to anxiety
* Seizure management (status epilepticus)
* Premedication for surgical procedures
## Adult Dosing
* **Anxiety:** 1-2 mg orally every 6-8 hours. Max: 10 mg/day.
* **Insomnia:** 2-4 mg orally at bedtime.
* **Status Epilepticus (IV/IM):** 4 mg. If seizure persists, a second dose of 4 mg may be given after 5-10 minutes. Max: 8 mg per dose.
## Pediatric Dosing
Dosing is highly variable and requires careful consideration of age, weight, and indication. Specific protocols are often utilized.
* **Anxiety/Sedation:** Often dosed by weight, e.g., 0.02-0.1 mg/kg orally every 4-8 hours.
* **Status Epilepticus (IV/IM):** 0.1 mg/kg (maximum 4 mg) per dose.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution, may require dose reduction.
* **Renal Impairment:** No specific adjustment, but monitor for accumulation.
* **Elderly:** Start with lower doses (e.g., 0.5-1 mg orally) and titrate slowly due to increased sensitivity to CNS effects.
## Contraindications
* Known hypersensitivity to lorazepam, other benzodiazepines, or any component of the formulation.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Myasthenia gravis.
## Adverse Effects
* **Common:** Drowsiness, sedation, dizziness, weakness, ataxia.
* **Less Common:** Confusion, depression, anterograde amnesia, paradoxical excitation, respiratory depression (especially with IV administration or in combination with other CNS depressants).
## Key Drug Interactions
* **CNS Depressants (opioids, alcohol, barbiturates, other sedatives):** Additive CNS depression, increased risk of respiratory depression and sedation. Use together cautiously, consider dose reduction of one agent.
* **Theophylline/Aminophylline:** May decrease the sedative effects of lorazepam.
* **Valproic acid:** May increase lorazepam levels.
## Monitoring
* Level of sedation and respiratory rate, especially after IV administration or with concomitant CNS depressants.
* Effectiveness for the intended indication.
* Signs of withdrawal upon discontinuation.
## Clinical Pearls
* Lorazepam has a relatively intermediate half-life among benzodiazepines.
* Avoid abrupt discontinuation; taper dose gradually to prevent withdrawal symptoms.
* IV lorazepam can be associated with phlebitis; dilute in appropriate solution if needed and administer slowly.
* Paradoxical reactions (agitation, aggression) are rare but can occur.
***
*Disclaimer: This information is intended for healthcare professionals. Always consult the most current prescribing information and institutional protocols before administering any medication. Dosing and recommendations may vary based on patient-specific factors and local guidelines.*
